医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
NBIX · NEUROCRINE BIOSCIENCES INC
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
NEUROCRINE BIOSCIENCES INC（NBIX）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $6.2M；高管董事有效买入 —、有效卖出 —。最近申报 2026-09-15。
买入 Bought—
卖出 Sold$6.2M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-14 | ABERNETHY MATT Chief Financial Officer | 卖出 Sell | 2,311 | $157.20 | $363K | SEC |
| 2026-09-14 | Boyer David W. Chief Corp. Affairs Officer | 卖出 Sell | 826 | $157.45 | $130K | SEC |
| 2026-09-09 | BENEVICH ERIC Chief Commercial Officer | 卖出 Sell | 2,154 | $154.61 | $333K | SEC |
| 2026-07-28 | Norwalk Leslie V Director | 卖出 Sell | 1,250 | $182.01 | $228K | SEC |
| 2026-07-10 | Delaet Ingrid Chief Regulatory Officer | 卖出 Sell | 4,367 | $181.02 | $791K | SEC |
| 2026-07-09 | Lippoldt Darin Chief Legal Officer | 卖出 Sell | 10,000 | $179.60 | $1.8M | SEC |
| 2026-07-07 | Delaet Ingrid Chief Regulatory Officer | 卖出 Sell | 14,571 | $178.65 | $2.6M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-14 | Boyer David W. Officer | 4,714 | $736K | 10b5-1 |
| 2026-09-14 | ABERNETHY MATT Officer | 2,311 | $361K | 10b5-1 |
| 2026-09-09 | BENEVICH ERIC Officer | 2,154 | $334K | 10b5-1 |
| 2026-07-10 | Delaet Ingrid Officer | 4,367 | $788K | 10b5-1 |
| 2026-07-09 | Lippoldt Darin Officer | 10,000 | $1.8M | 10b5-1 |
| 2026-07-07 | Delaet Ingrid Officer | 14,571 | $2.5M | 10b5-1 |
内部人 Insiders
ABERNETHY MATT、Boyer David W.、BENEVICH ERIC、Norwalk Leslie V、Delaet Ingrid、Lippoldt Darin